In this study, we analysed a possibly immunomodulating mechanism by which MSCs could reduce the population and maturation of CD103+ DCs, alleviate CD103+ DCs‐mediated CD8 T cell responses, ameliorate local inflammation and exhibit a protective effect in the diseased kidney of DN rat. This evidence concerns the gene CD8A and liver dysplastic nodule.